Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Hansoh Pharmaceutical Group Company Limited ( (HK:3692) ) is now available.
Hansoh Pharmaceutical Group Company Limited announced an interim dividend of HKD 0.2316 per share for the six months ending June 30, 2025. The dividend will be paid on October 30, 2025, and reflects the company’s strong financial performance and commitment to delivering value to its shareholders. This announcement may positively impact the company’s market position and investor confidence.
The most recent analyst rating on (HK:3692) stock is a Buy with a HK$34.83 price target. To see the full list of analyst forecasts on Hansoh Pharmaceutical Group Company Limited stock, see the HK:3692 Stock Forecast page.
More about Hansoh Pharmaceutical Group Company Limited
Hansoh Pharmaceutical Group Company Limited operates in the pharmaceutical industry, focusing on the development, production, and sale of innovative and high-quality medicines. The company is known for its commitment to addressing critical healthcare needs and enhancing patient outcomes.
Average Trading Volume: 11,591,839
Technical Sentiment Signal: Buy
Current Market Cap: HK$221.8B
See more insights into 3692 stock on TipRanks’ Stock Analysis page.
Trending Articles:
- Boeing Stock (NYSE:BA) Notches Up as Strike Starts to Hurt
- “You’re Going to Burn This Billion Dollars.” Microsoft Stock (NASDAQ:MSFT) Slumps on Original Assessment of OpenAI
- “7.5 Years Has Felt like a Long Time to Wait.” Sam Altman Wants His Roadster Deposit Back, Tesla Stock (NASDAQ:TSLA) Jumps Regardless